These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5392784)

  • 21. The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.
    Chiou VY
    Clin Toxicol (Phila); 2008 Jul; 46(6):539-44. PubMed ID: 18584367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute pituitary necrosis following snake envenomation.
    Murthy GL; Krishanaprasad A; Srinivasan VR; Sundaram S
    J Assoc Physicians India; 2002 Mar; 50():452-3. PubMed ID: 11922244
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyaluronidase and protease activities from Indian snake venoms: neutralization by Mimosa pudica root extract.
    Girish KS; Mohanakumari HP; Nagaraju S; Vishwanath BS; Kemparaju K
    Fitoterapia; 2004 Jun; 75(3-4):378-80. PubMed ID: 15159000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the route of administration on the neutralizing potency of antivenins.
    Kocholaty WF; Billings TA; Ashley BD; Ledford EB; Goetz JC
    Toxicon; 1968 Feb; 5(3):165-70. PubMed ID: 4170738
    [No Abstract]   [Full Text] [Related]  

  • 25. Snake venoms and antivenoms: critical supply issues.
    Bawaskar HS
    J Assoc Physicians India; 2004 Jan; 52():11-3. PubMed ID: 15633710
    [No Abstract]   [Full Text] [Related]  

  • 26. [Snake venoms, as a source of anticancerous enzymes. II. Experimental study].
    Wirtheimer C; Gillo L
    Mem Inst Butantan; 1966; 33(3):937-42. PubMed ID: 6002977
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cobra bites].
    Satora L; Morawska J; Targosz D
    Przegl Lek; 2003; 60(4):202-3. PubMed ID: 14569884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised control trial on the effective dose of anti-snake venom in cases of snake bite with systemic envenomation.
    Seth AK; Varma PP; Pakhetra R
    J Assoc Physicians India; 2000 Jul; 48(7):756. PubMed ID: 11273522
    [No Abstract]   [Full Text] [Related]  

  • 29. Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms.
    Laing GD; Yarleque A; Marcelo A; Rodriguez E; Warrell DA; Theakston RD
    Toxicon; 2004 Jul; 44(1):103-6. PubMed ID: 15225568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom.
    Gutiérrez JM; Sanz L; Escolano J; Fernández J; Lomonte B; Angulo Y; Rucavado A; Warrell DA; Calvete JJ
    J Proteome Res; 2008 Oct; 7(10):4396-408. PubMed ID: 18785768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemorrhagic and proteolytic activities of Thailand snake venoms.
    Tu AT; Toom PM; Ganthavorn S
    Biochem Pharmacol; 1967 Nov; 16(11):2125-30. PubMed ID: 6076606
    [No Abstract]   [Full Text] [Related]  

  • 32. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus.
    Queiroz GP; Pessoa LA; Portaro FC; Furtado Mde F; Tambourgi DV
    Toxicon; 2008 Dec; 52(8):842-51. PubMed ID: 18983867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorrhagic, myonecrotic, thrombotic and proteolytic activities of viper venoms.
    Tu AT; Homma M; Hong BS
    Toxicon; 1969 Feb; 6(3):175-8. PubMed ID: 5776833
    [No Abstract]   [Full Text] [Related]  

  • 35. [Snake venoms].
    Imaizumi H; Kaneko M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):668-71. PubMed ID: 10434745
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba.
    da Silva JO; Coppede JS; Fernandes VC; Sant'ana CD; Ticli FK; Mazzi MV; Giglio JR; Pereira PS; Soares AM; Sampaio SV
    J Ethnopharmacol; 2005 Aug; 100(1-2):145-52. PubMed ID: 16054531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?].
    Mebs D
    MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
    Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
    Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity in monkeys of a combined toxoid from the main toxic principles separated from Habu snake venom.
    Kondo H; Sadahiro S; Kondo S; Yamauchi K; Honjo S
    Jpn J Med Sci Biol; 1970 Dec; 23(6):413-8. PubMed ID: 4994228
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical and biological characterization of the venoms of Bothriopsis bilineata and Bothriopsis taeniata (Serpentes: Viperidae).
    Porto BN; Telli CA; Dutra TP; Alves LS; Bozza MT; Fin CA; Thiesen FV; Renner MF
    Toxicon; 2007 Aug; 50(2):270-7. PubMed ID: 17537475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.